Fundz

Eterna Therapeutics reported raising $8.72 Million in an initial SEC Form D filing, from an offering of $8.72 Million

PUBLIC · ERNAJul 26, 2023

Amount Raised

$8.72 Million

$8.72 Million sold, per SEC Form D (first sale Jul 14, 2023)

Round Type

Venture

CambridgeBiotechnologyTherapeutics

Quick answer

Ernexa Therapeutics Inc. raised $8.72 Million in a funding round, dated July 14, 2023. Ernexa Therapeutics Inc. is based in Cambridge, Massachusetts, United States.

How much did Ernexa Therapeutics Inc. raise?
Ernexa Therapeutics Inc. raised $8.72 Million in a funding round on July 14, 2023.
What does Ernexa Therapeutics Inc. do?
Eterna Therapeutics is a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines.
Where is Ernexa Therapeutics Inc. based and how big is it?
Ernexa Therapeutics Inc. is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Ernexa Therapeutics Inc?
Fundz holds 2 contacts at Ernexa Therapeutics Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Ernexa Therapeutics Inc., and when

A new round usually means Ernexa Therapeutics Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ernexa Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ernexa Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ernexa Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ernexa Therapeutics Inc.

Location

10355 Science Center Drive

Cambridge, Massachusetts, United States

About

Eterna Therapeutics is a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines. Eterna has in-licensed a portfolio of over 130 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice™ and UltraSlice™ gene-editing proteins, and the ToRNAdo™ mRNA delivery system from Factor Bioscience.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ernexa Therapeutics Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts10 people are listed at Ernexa Therapeutics Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ernexa Therapeutics Inc.'s next move

See what Strategic adds

Ernexa Therapeutics Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.